These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8834018)

  • 1. Hepatitis B virus surface mutations associated with infection after liver transplantation.
    Hawkins AE; Gilson RJ; Gilbert N; Wreghitt TG; Gray JJ; Ahlers-de Boer I; Tedder RS; Alexander GJ
    J Hepatol; 1996 Jan; 24(1):8-14. PubMed ID: 8834018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-core mutants of hepatitis B virus in patients receiving immunosuppressive treatment after orthotopic liver transplantation.
    Protzer U; Goergen B; Hopf U; Neuhaus P; König V; Meyer zum Büschenfelde KH; Gerken G
    J Med Virol; 1996 Oct; 50(2):135-44. PubMed ID: 8915879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients.
    Ijaz S; Torre F; Tedder RS; Williams R; Naoumov NV
    J Med Virol; 2001 Mar; 63(3):210-6. PubMed ID: 11170059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant.
    Fang JW; Tung FY; Davis GL; Dolson DJ; Van Thiel DH; Lau JY
    Gastroenterology; 1993 Sep; 105(3):901-4. PubMed ID: 8359657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy.
    Kim KH; Lee KH; Chang HY; Ahn SH; Tong S; Yoon YJ; Seong BL; Kim SI; Han KH
    J Med Virol; 2003 Nov; 71(3):367-75. PubMed ID: 12966541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis.
    Sterneck M; Günther S; Gerlach J; Naoumov NV; Santantonio T; Fischer L; Rogiers X; Greten H; Williams R; Will H
    J Hepatol; 1997 Apr; 26(4):754-64. PubMed ID: 9126786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation.
    Mutimer D; Pillay D; Dragon E; Tang H; Ahmed M; O'Donnell K; Shaw J; Burroughs N; Rand D; Cane P; Martin B; Buchan S; Boxall E; Barmat S; Gutekunst K; McMaster P; Elias E
    J Hepatol; 1999 Apr; 30(4):715-21. PubMed ID: 10207815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation.
    Rodriguez-Frias F; Buti M; Jardi R; Vargas V; Quer J; Cotrina M; Martell M; Esteban R; Guardia J
    Liver; 1999 Jun; 19(3):177-82. PubMed ID: 10395035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
    Ueda Y; Marusawa H; Egawa H; Okamoto S; Ogura Y; Oike F; Nishijima N; Takada Y; Uemoto S; Chiba T
    Antivir Ther; 2011; 16(4):479-87. PubMed ID: 21685535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression.
    Lenci I; Baiocchi L; Tariciotti L; Di Paolo D; Milana M; Santopaolo F; Manzia TM; Toti L; Svicher V; Tisone G; Perno CF; Angelico M
    Liver Transpl; 2016 Sep; 22(9):1205-13. PubMed ID: 27272189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of different viral strains of hepatitis B virus in chronically infected children after seroconversion from HBsAg to anti-HBs indicating viral persistence.
    Bahn A; Gerner P; Martiné U; Bortolotti F; Wirth S
    J Hepatol; 1997 Dec; 27(6):973-8. PubMed ID: 9453421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo and apparent de novo hepatitis B virus infection after liver transplantation.
    Roche B; Samuel D; Gigou M; Feray C; Virot V; Schmets L; David MF; Arulnaden JL; Bismuth A; Reynes M; Bismuth H
    J Hepatol; 1997 Mar; 26(3):517-26. PubMed ID: 9075658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B.
    Kato J; Hasegawa K; Torii N; Yamauchi K; Hayashi N
    Hepatology; 1996 Mar; 23(3):389-95. PubMed ID: 8617416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of wild-type and precore mutant HBV infection after liver transplantation.
    Torre F; Wong PY; Macartney M; Williams R; Naoumov NV
    J Med Virol; 1999 Sep; 59(1):5-13. PubMed ID: 10440801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
    Kim KH; Ahn SH; Chung HY; Paik YH; Lee KS; Kim YS; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2004 Aug; 19(8):847-53. PubMed ID: 15242485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo acute hepatitis B infection in a previously vaccinated liver transplant recipient due to a strain of HBV with a Met 133 Thr mutation in the "a" determinant.
    Yoshida EM; Ramji A; Erb SR; Davis JE; Steinbrecher UP; Sherlock CH; Scudamore CH; Chung SW; Williams M; Gutfreund KS
    Liver; 2000 Oct; 20(5):411-4. PubMed ID: 11092260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients.
    McMahon G; Ehrlich PH; Moustafa ZA; McCarthy LA; Dottavio D; Tolpin MD; Nadler PI; Ostberg L
    Hepatology; 1992 May; 15(5):757-66. PubMed ID: 1568715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization.
    Müller R; Gubernatis G; Farle M; Niehoff G; Klein H; Wittekind C; Tusch G; Lautz HU; Böker K; Stangel W
    J Hepatol; 1991 Jul; 13(1):90-6. PubMed ID: 1918881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retransplantation of patients with severe posttransplant hepatitis B in the first allograft.
    Ishitani M; McGory R; Dickson R; Caldwell S; Bickston S; McCullough C; Pruett T; Terrault N; Roberts J; Ascher N; Wright T; Lake J
    Transplantation; 1997 Aug; 64(3):410-4. PubMed ID: 9275104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.